Sunday, 27 January 2019

New High Yield Group within SIPP

These days, I'm becoming increasingly uncomfortable with holding large chunks of individual company shares, preferring instead to spread the perceived risk by using funds and trusts that invest across many companies.  I must be getting old ...

Within my combined portfolio, Centrica (CNA.L), GlaxoSmithKline (GSK.L) and Royal Dutch Shell (RDSB.L) may each be a relatively small piece of the whole, but if considered together they'd become my largest equity holding and be quite significant in actual cash terms.

And there's good reason to link them together.  These three shares are amongst the largest contributors to my passive income stream, and in combination produced 18% of last year's total income despite comprising just 6.5% of the total portfolio valuation at the year end. Understandably therefore, I'm very reluctant to ditch them altogether.   

So instead, a few days ago I created my own high-yield 'fund' by actually increasing the number of individual shares within the portfolio but using much smaller holdings.


Tuesday, 1 January 2019

Investment Review - December 2018

And so this is Christmas, and how have we done ?  

Firstly, the combined portfolio spreadsheet updated on Monday 31 December 2018.